{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:30:52Z","timestamp":1791261052571,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jns.2016.02.012","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T01:47:17Z","timestamp":1454809637000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study"],"prefix":"10.1016","volume":"363","author":[{"given":"Laure","family":"Peyro Saint Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Creveuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Heinzlef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"De Seze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vermersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Castelnovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Debouverie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Brochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lebiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Clavelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lebrun-Frenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Daplaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne","family":"Coman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hautecoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Tourbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Defer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.02.012_bb0005","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","article-title":"Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10years","volume":"58","author":"Amato","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1474-4422(05)70166-6","article-title":"Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing","volume":"4","author":"Mitchell","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0015","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s00415-012-6678-0","article-title":"Treatment of cognitive impairment in multiple sclerosis: position paper","volume":"260","author":"Amato","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0020","first-page":"181","article-title":"Cognitive effects of symptomatic and disease treatments","author":"Defer","year":"2010","journal-title":"Neuropsychology of Multiple Sclerosis"},{"key":"10.1016\/j.jns.2016.02.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008876.pub2","article-title":"Pharmacologic treatment for memory disorder in multiple sclerosis","volume":"10","author":"He","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2016.02.012_bb0030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2016.02.012_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2016.02.012_bb0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneurol.2011.69","article-title":"Lack of evidence for the efficacy of memantine in mild Alzheimer disease","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0045","first-page":"339","article-title":"Alzheimer disease pharmacologic treatment and treatment research","volume":"19","author":"Schneider","year":"2013","journal-title":"Continuum"},{"key":"10.1016\/j.jns.2016.02.012_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1469-7580.2010.01339.x","article-title":"Glutamate and ATP signalling in white matter pathology","volume":"219","author":"Matute","year":"2011","journal-title":"J. Anat."},{"key":"10.1016\/j.jns.2016.02.012_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","article-title":"The link between excitotoxic oligodendroglial death and demyelinating diseases","volume":"24","author":"Matute","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jns.2016.02.012_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.24202","article-title":"In vivo evidence of glutamate toxicity in multiple sclerosis","volume":"76","author":"Azevedo","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1476-5381.2012.02178.x","article-title":"Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis","volume":"168","author":"Grasselli","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jns.2016.02.012_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.05.006","article-title":"Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis","volume":"261","author":"Sulkowski","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2016.02.012_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/NEN.0000000000000073","article-title":"N-methyl-d-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis","volume":"73","author":"S\u00fchs","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0080","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/brain\/awh467","article-title":"Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T","volume":"128","author":"Srinivasan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.02.012_bb0085","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000342388.73185.80","article-title":"Memantine induces reversible neurologic impairment in patients with MS","volume":"72","author":"Villoslada","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.012_bb0090","doi-asserted-by":"crossref","unstructured":"Lovera J.F., Frohman E., Brown T.R., Bandari D., Nguyen L., Yadav V., Stuve O., Karman J., Bogardus K., Heimburger G., Cua L., Remingon G., Fowler J., Monahan T., Kilcup S., Courtney Y., McAleenan J., Butler K., Wild K., Whitham R., Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial, Mult. Scler. 16 (2010) 715-723. DOI: http:\/\/dx.doi.org\/10.1177\/1352458510367662.","DOI":"10.1177\/1352458510367662"},{"key":"10.1016\/j.jns.2016.02.012_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international Panel on the Diagnosis of Multiple Sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.012_bb0105","series-title":"Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians","first-page":"77","article-title":"Mental status examination for organic mental syndrome in the elderly patient","author":"Mattis","year":"1976"},{"key":"10.1016\/j.jns.2016.02.012_bb0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2466\/pms.1977.44.2.367","article-title":"Paced auditory serial-addition task: a measure of recovery from concussion","volume":"44","author":"Gronwall","year":"1977","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/j.jns.2016.02.012_bb0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.neurol.2010.01.018","article-title":"Paced auditory serial addition test: normative data in a French population","volume":"166","author":"Reuter","year":"2010","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jns.2016.02.012_bb0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jns.2016.02.012_bb0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.acn.2005.07.006","article-title":"A comprehensive review of the paced auditory serial addition test (PASAT)","volume":"21","author":"Tombaugh","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jns.2016.02.012_bb0130","series-title":"Applied Neuropsychology of Attention: Theory, Diagnosis and Rehabilitation","first-page":"110","article-title":"A test battery for attentional performance","author":"Zimmermann","year":"2002"},{"issue":"5","key":"10.1016\/j.jns.2016.02.012_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00406-005-0565-y","article-title":"Attention and memory dysfunctions in mild multiple sclerosis","volume":"255","author":"Tinnefeld","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2016.02.012_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/jnnp.64.4.455","article-title":"Computer assisted retraining of attentional impairments in patients with multiple sclerosis","volume":"64","author":"Plohmann","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.02.012_bb0145","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0b013e31828cf82f","article-title":"Cognitive impairment differs between primary progressive and relapsing-remitting MS","volume":"80","author":"Ruet","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2016.02.012_bb0150","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/1352458513480251","article-title":"A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis","volume":"19","author":"Ruet","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.02.012_bb0155","series-title":"Adult Intelligence Scale (WAIS-IIIuk): Wechsler Memory Scale (WMS-IIIuk)","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.jns.2016.02.012_bb0160","unstructured":"Online Product Information EBIXA http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000463\/WC500058763.pdf."},{"key":"10.1016\/j.jns.2016.02.012_bb0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/01.WNL.0000129828.03714.90","article-title":"Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS","volume":"63","author":"Huijbregts","year":"2004","journal-title":"Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0170","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.02.012_bb0175","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/WNL.0b013e3181d9ed91","article-title":"Default-mode network dysfunction and cognitive impairment in progressive MS","volume":"74","author":"Rocca","year":"2010","journal-title":"Neurol."},{"key":"10.1016\/j.jns.2016.02.012_bb0180","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/npp.2008.200","article-title":"A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia","volume":"34","author":"Lieberman","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2016.02.012_bb0185","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/pds.3471","article-title":"Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study","volume":"22","author":"Laroche","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jns.2016.02.012_bb0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00228-002-0493-y","article-title":"Adverse drug reactions and cognitive function among hospitalized older adults","volume":"58","author":"Onder","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2016.02.012_bb0195","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000101454","article-title":"Adverse drug events in cognitively impaired elderly patients","volume":"23","author":"Ganjavi","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2016.02.012_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2202-8-55","article-title":"Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity","volume":"26","author":"Li","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jns.2016.02.012_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067357","article-title":"Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis","volume":"8","author":"Rossi","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16300776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16300776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T22:47:37Z","timestamp":1600123657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16300776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":41,"alternative-id":["S0022510X16300776"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}